NAll news

All news

Wednesday142 items

  4. heise online
    AI score56

    Apple tightens App Store rules, explicitly banning Nudify apps and bait-and-switch apps

    Apple has revised its App Store Review Guidelines, requiring under Rule 1.2 that developers proactively prevent AI-generated pornographic deepfake content within their apps and remove such content, or Apple may remove the app. The new Rule 2.5.19 targets bait-and-switch apps, meaning programs whose actual functionality does not match their promotion and that only unlock features later; Apple may immediately delete them and revoke developer eligibility. The report notes that the Grok app had previously allowed the generation of problematic deepfake content, and that SpaceXAI responded only after Apple threatened to remove it.

    Same story · 2 reports

    #English text is being prepared.#Image generation#Safety / alignment

  9. Analytics India Magazine
    AI score61

    NVIDIA GTC Berlin 2026 announces 12 releases, covering AI factories, telecommunications, and enterprise agents

    At GTC 2026 in Berlin, NVIDIA announced 12 releases, covering AI factory deployment, semiconductor manufacturing expansion, telecom AI-RAN, enterprise agents, robotics and autonomous driving, as well as new open models for enterprise data, protein design, and quantum computing. On the infrastructure side, the DSX POD modular AI factory reference design is said to shorten deployment time from six months to as little as 14 days, and DSX MaxLPS is said to deliver equivalent AI compute using up to 30% less power, with partners planning to deliver in early 2027. On the telecom side, T-Mobile completed what it calls the world's first AI-RAN call on a commercial network in Bellevue, Washington, with NVIDIA and Nokia, and Elisa completed Europe's first AI-RAN field trial; on the enterprise side, it expanded the open-source Agent Toolkit and introduced the OpenShell reference architecture for monitoring and restricting agent behavior.

    #Industry news#English text is being prepared.#English text is being prepared.

  10. Analytics India Magazine
    AI score66

    OpenAI acquires Orchestra Bio to build AI agents for drug discovery

    OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug discovery projects; the terms of the deal were not disclosed. Orchestra Bio was founded in 2022 and had raised approximately $20 million by 2025, with investors including Andreessen Horowitz, Atria Ventures, and 8VC. Its team and technology will be integrated into OpenAI's Rosalind model and tool suite for life sciences research, and the two sides plan to develop AI agents capable of connecting scientific discovery with the research, decision-making, and workflows needed to advance drug candidates.

    Same story · 8 reports

    #Industry news#Agents#OpenAI

  15. Analytics India Magazine
    AI score73

    U.S. Department of Homeland Security requires federal civilian agencies to remove DeepSeek

    The U.S. Department of Homeland Security (DHS) has ordered federal civilian agencies to immediately stop procuring DeepSeek products and services and to remove them from government information technology systems; the order applies to civilian executive branch agencies, excludes national security systems, and does not restrict public use of DeepSeek. DHS says the DeepSeek model has multiple threat vectors, with reasons including servers located in China, account registration collecting personally identifiable information, multiple critical vulnerabilities found in the iOS app, and prompt interactions potentially allowing sensitive data to leak out. China's Ministry of Commerce responded that it consistently opposes over-broadening the concept of national security and politicizing science, technology and trade issues, and stated it will take all necessary measures to safeguard the legitimate rights and interests of Chinese enterprises.

    Same story · 15 reports

    #English text is being prepared.#DeepSeek

  18. The Decoder
    AI score69

    OpenAI Acquires Orchestra Bio, Merging It Into Life Sciences Platform Rosalind

    OpenAI has acquired Orchestra Bio, a startup that helps pharmaceutical companies coordinate drug development, and merged it into Rosalind, its AI platform for life sciences. Orchestra's agents can track clinical trials, flag affected timelines when problems such as failed batches arise, and present follow-up options. OpenAI says the move is aimed at building AI agents that connect scientific discovery with clinical trials and decision-making to speed new drugs to market; a new drug in the United States takes an average of 10 to 15 years to develop, and the deal amount was not disclosed.

    #Industry news#Agents#OpenAI